UB Paderborn / Katalog / Suche / in CDI

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma – Impact on prognosis

European journal of surgical oncology, 2016-03, Vol.42 (3), p.419-425

2016

Link zum Volltext

Verfügbarkeit prüfen

Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma

Prostate cancer and prostatic diseases, 2011-03, Vol.14 (1), p.38-45

2011

Link zum Volltext

Verfügbarkeit prüfen

Aspects techniques de la préservation nerveuse au cours de la prostatectomie rétropubienne

Annales d'urologie, 2007-02, Vol.41 (1), p.23-30

2007

Link zum Volltext

Verfügbarkeit prüfen

Stellenwert der CT-gesteuerten perkutanen Biopsie kleiner Tumoren in der Diagnostik des Nierenzellkarzinoms: aktueller Stand

Der Onkologe, 2008-10, Vol.14 (10), p.1022-1031

2008

Link zum Volltext

Verfügbarkeit prüfen

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

European journal of cancer (1990), 2012-02, Vol.48 (3), p.324-332

2012

Link zum Volltext

Verfügbarkeit prüfen

Urethral reconstruction using buccal mucosa transplants

Urologe. Ausgabe A, 2013-05, Vol.52 (5), p.650

2013

Link zum Volltext

Verfügbarkeit prüfen

Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy

European urology, 2006-06, Vol.49 (6), p.1011-1018

2006

Link zum Volltext

Verfügbarkeit prüfen

Technical aspects of nerve sparing during retropubic prostatectomy

Annales d'urologie, 2007-02, Vol.41 (1), p.23-30

2007

Link zum Volltext

Verfügbarkeit prüfen

Technical aspects of nerve sparing during retropubic prostatectomy

Annales d'urologie, 2007-02, Vol.41 (1), p.23

2007

Link zum Volltext

Verfügbarkeit prüfen

The 2002 AJCC pT2 Substages Confer No Prognostic Information on the Rate of Biochemical Recurrence After Radical Prostatectomy

European urology, 2006-02, Vol.49 (2), p.273-279

2006

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Risikostratifizierung beim Nierenzellkarzinom

Onkologie (Heidelberg, Germany), 2008-10, Vol.14 (10), p.1071-1076

2008

Link zum Volltext

Verfügbarkeit prüfen

Immuntherapie des metastasierten Nierenzellkarzinoms

Onkologie (Heidelberg, Germany), 2008-10, Vol.14 (10), p.1040-1047

2008

Link zum Volltext

Verfügbarkeit prüfen

323 Serum and urine biomarker profile of kidney injury after (partial) tumor nephrectomy

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e323-e323

2014

Link zum Volltext

Verfügbarkeit prüfen

426 Laparoscopic vs open partial nephrectomy for clinical T1 renal masses: No impact of surgical approach on perioperative complications and longterm post-operative quality of life

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e426-e426

2014

Link zum Volltext

Verfügbarkeit prüfen

Laparoskopische Nierenteilresektion

Onkologie (Heidelberg, Germany), 2008-10, Vol.14 (10), p.992

2008

Link zum Volltext

Verfügbarkeit prüfen

Selektionskriterien zum abwartenden Management des lokalisierten Prostatakarzinoms

Urologe. Ausgabe A, 2005-11, Vol.44 (11), p.1277-1286

2005

Link zum Volltext

Verfügbarkeit prüfen

Radikale retropubische „Fast-track-Prostatektomie: Erste Erfahrungen mit einem interdisziplinären, multimodalen Behandlungskonzept zur Beschleunigung der postoperativen Rehabilitation

Urologe. Ausgabe A, 2005-11, Vol.44 (11), p.1287-1294

2005

Link zum Volltext

Verfügbarkeit prüfen

251 SEQUENTIAL USE OF THE TYROSIN KINASE INHIBITORS SORAFENIB AND SUNITINIB

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.183-183

2009

Link zum Volltext

Verfügbarkeit prüfen

83 International, expanded-access programme of everolimus in patients with metastatic renal cell carcinoma who progressed after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: Sub-analysis of European patients

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e83-e83a

2012

Link zum Volltext

Verfügbarkeit prüfen

157 High rates of significant prostate cancer are detectable in repeat biopsies

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e157-e157

2012

Link zum Volltext

Verfügbarkeit prüfen

1021 A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e1021-e1021

2012

Link zum Volltext

Verfügbarkeit prüfen

1014 OLDER PATIENTS SUFFER FROM DELAYED RADICAL CYSTECTOMY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.318-318

2010

Link zum Volltext

Verfügbarkeit prüfen

267 LOSS OF EPITHELIAL CELL ADHESION MOLECULE (EPCAM) IS ASSOCIATED WITH POOR OVERALL SURVIVAL IN CLEAR CELL RENAL CARCINOMA (CCRCC) - RESULTS OF A LARGE TMA-BASED ANALYSIS

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.104-105

2011

Link zum Volltext

Verfügbarkeit prüfen

863 LONG-TERM SURVIVAL WITH INHALATIONAL IL-2 THERAPY IN CARDIAC HIGH RISK PATIENTS WITH METASTATIC RENAL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.238-238

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma – Impact on prognosis

Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma

Aspects techniques de la préservation nerveuse au cours de la prostatectomie rétropubienne

Stellenwert der CT-gesteuerten perkutanen Biopsie kleiner Tumoren in der Diagnostik des Nierenzellkarzinoms: aktueller Stand

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Urethral reconstruction using buccal mucosa transplants

Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy

Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)

Technical aspects of nerve sparing during retropubic prostatectomy

Technical aspects of nerve sparing during retropubic prostatectomy

The 2002 AJCC pT2 Substages Confer No Prognostic Information on the Rate of Biochemical Recurrence After Radical Prostatectomy

Perioperative Risikostratifizierung beim Nierenzellkarzinom

Immuntherapie des metastasierten Nierenzellkarzinoms

323 Serum and urine biomarker profile of kidney injury after (partial) tumor nephrectomy

426 Laparoscopic vs open partial nephrectomy for clinical T1 renal masses: No impact of surgical approach on perioperative complications and longterm post-operative quality of life

Laparoskopische Nierenteilresektion

Selektionskriterien zum abwartenden Management des lokalisierten Prostatakarzinoms

Radikale retropubische „Fast-track-Prostatektomie: Erste Erfahrungen mit einem interdisziplinären, multimodalen Behandlungskonzept zur Beschleunigung der postoperativen Rehabilitation

251 SEQUENTIAL USE OF THE TYROSIN KINASE INHIBITORS SORAFENIB AND SUNITINIB

83 International, expanded-access programme of everolimus in patients with metastatic renal cell carcinoma who progressed after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: Sub-analysis of European patients

157 High rates of significant prostate cancer are detectable in repeat biopsies

1021 A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe

1014 OLDER PATIENTS SUFFER FROM DELAYED RADICAL CYSTECTOMY

267 LOSS OF EPITHELIAL CELL ADHESION MOLECULE (EPCAM) IS ASSOCIATED WITH POOR OVERALL SURVIVAL IN CLEAR CELL RENAL CARCINOMA (CCRCC) - RESULTS OF A LARGE TMA-BASED ANALYSIS

863 LONG-TERM SURVIVAL WITH INHALATIONAL IL-2 THERAPY IN CARDIAC HIGH RISK PATIENTS WITH METASTATIC RENAL CARCINOMA

Suchergebnisse filtern